Private Equity Firm • Multi-Strategy • North America

MedImmune Ventures

AUM

Not publicly reported

Estimated Dry Powder

Not publicly reported

Fund Size (Latest)

Not publicly reported

Estimated Cheque Size

Not publicly reported

Stages

Angel
Seed
Series A

Fund Details

Year Established

2002

Website

https://www.astrazeneca.com

One MedImmune Way, Gaithersburg, MD, 20878, US, North America

HQ Phone

About

MedImmune Ventures is a wholly-owned venture capital firm within the AstraZeneca/MedImmune group of companies. MedImmune Ventures invests in early- to late-stage, public or private biotechnology companies focused on discovering and developing human therapeutics across North America, US. The firm primarily seeks to invest in areas of strategic interest to Astra Zeneca and MedImmune, including infectious diseases, cancer, inflammatory diseases, cardiovascular and metabolic disorders, pain and central nervous system disorders, and gastrointestinal disease. MedImmune invests anywhere in the world where it has strong local relationships.

HQ Map

No mappable locations available.

Locations

One MedImmune Way, Gaithersburg, MD, 20878, US, North America

View map

1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AA, UK, Europe

Tel: +44 0 20 3749 5000View map

121 Oyster Point Boulevard, South San Francisco, CA, 94080, US, North America

View map

1800 Concord Pike, Wilmington, DE, 19850, US, North America

Tel: +1 800 456 3669View map

35 Gatehouse Drive, Waltham, MA, 02451, US, North America

Tel: +1 781 839 4000View map

701 Pennsylvania Avenue NW # 500, Washington, DC, 20004, US, North America

Tel: +1 202 350 5500View map

Aaron Klug Building,Granta Park, Cambridge, CB21 6GH, UK, Europe

Tel: +44 (0) 1223 471 471View map

No. 199, Liangjing Road, Pudong New Area, Pudong, Shanghai, China, Asia

View map

Storgatan 51,151 36, Södertälje, Sweden, Europe

Tel: +46 8 553 260 00View map